Eyes on the prize: Sanders’ radical patent reform on Congress agenda

Opponents of drug monopolies hope a Senate amendment could be a watershed moment for US patent policy
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: